Neuraxpharm Group, a European specialty pharmaceutical company focused on the central nervous system, has expanded its operations in Southern Europe with the launch of Neuraxpharm Portugal, it was reported yesterday.
The new office will be part of the company's Southern European Region that includes Italy, Spain and now Portugal.
Javier Mercade, general manager for Italy and Spain, was named as head of the Southern Region earlier this year, which will include Spain, Italy and Portugal. The company has also named Teng Dias as commercial director of the Portugal business.
Kibow Biotech receives AANP Corporation of the Year Award
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees